Filing Details
- Accession Number:
- 0001209191-17-021568
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-03-17 19:35:38
- Reporting Period:
- 2017-03-16
- Filing Date:
- 2017-03-17
- Accepted Time:
- 2017-03-17 19:35:38
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1326732 | Xencor Inc | XNCR | Pharmaceutical Preparations (2834) | 201622502 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1591306 | J John Kuch | C/O Xencor, Inc. 111 West Lemon Avenue Monrovia CA 91016 | Vice President, Finance | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-03-16 | 24,516 | $0.59 | 92,171 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-03-16 | 15,000 | $24.42 | 77,171 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2017-03-16 | 24,516 | $0.00 | 24,516 | $0.59 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2020-09-30 | No | 4 | M | Direct |
Footnotes
- Includes 577 shares of Common Stock that were acquired by the Reporting Person on December 10, 2016 pursuant to the Issuer's Employee Stock Purchase Plan.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.40 to $24.75, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities andExchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- The option was fully vested on October 1, 2014.
Billionaire Hedge Funds
